Radiation dose escalation with modified fractionation schedules for locally advanced NSCLC: A systematic review.
Acute esophagitis
EQD2,T
modified fractionation
radiation dose escalation
systematic review
Journal
Thoracic cancer
ISSN: 1759-7714
Titre abrégé: Thorac Cancer
Pays: Singapore
ID NLM: 101531441
Informations de publication
Date de publication:
06 2020
06 2020
Historique:
received:
27
02
2020
revised:
04
04
2020
accepted:
05
04
2020
pubmed:
24
4
2020
medline:
12
3
2021
entrez:
24
4
2020
Statut:
ppublish
Résumé
Concomitant chemo-radiotherapy (cCRT) with 60 Gy in 30 fractions is the standard of care for stage 111 non-small cell lung cancer (NSCLC). With a median overall survival of 28.7 months at best and maximum locoregional control rates of 70% at two years, the prognosis for these patients is still dismal. This systematic review summarizes data on dose escalation by alternative fractionation, which has been explored as a primary strategy to improve both local control and overall survival over the past three decades. A Pubmed literature search was performed according to the PRISMA guidelines. Because of the large variety of radiation regimens total doses were converted to EQD
Identifiants
pubmed: 32323484
doi: 10.1111/1759-7714.13451
pmc: PMC7262927
doi:
Types de publication
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1375-1385Informations de copyright
© 2020 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd.
Références
J Clin Oncol. 2010 Mar 10;28(8):1380-6
pubmed: 20142596
Eur J Cancer. 2014 Nov;50(17):2939-49
pubmed: 25304298
J Clin Oncol. 1999 Sep;17(9):2692-9
pubmed: 10561343
Int J Radiat Oncol Biol Phys. 2000 Jan 15;46(2):516-7
pubmed: 10661362
Clin Lung Cancer. 2015 Mar;16(2):71-9
pubmed: 25450876
Chest. 2000 Feb;117(2):358-64
pubmed: 10669675
Lung Cancer. 2004 Oct;46(1):87-98
pubmed: 15364136
Eur J Cancer. 2007 Jan;43(1):114-21
pubmed: 17084621
Ann Oncol. 2015 Aug;26(8):1573-88
pubmed: 25897013
Radiother Oncol. 2011 Jul;100(1):76-85
pubmed: 21757247
Lung Cancer. 2009 Jul;65(1):62-7
pubmed: 19081652
J Clin Oncol. 2005 Sep 1;23(25):5910-7
pubmed: 16087956
Radiat Oncol. 2014 Aug 29;9:190
pubmed: 25174943
Radiother Oncol. 2012 Feb;102(2):228-33
pubmed: 22100659
N Engl J Med. 1990 Oct 4;323(14):940-5
pubmed: 2169587
N Engl J Med. 2017 Nov 16;377(20):1919-1929
pubmed: 28885881
Clin Oncol (R Coll Radiol). 2010 Jun;22(5):347-55
pubmed: 20427167
Radiother Oncol. 2009 Dec;93(3):396-401
pubmed: 19435642
Ann Oncol. 2019 May 1;30(5):781-787
pubmed: 30887043
Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):1117-22
pubmed: 15752891
Int J Radiat Oncol Biol Phys. 1990 Oct;19(4):1071-5
pubmed: 2211245
Int J Radiat Oncol Biol Phys. 2004 Nov 15;60(4):1241-56
pubmed: 15519797
Clin Oncol (R Coll Radiol). 2018 Jan;30(1):30-38
pubmed: 29097074
Anticancer Res. 2018 Oct;38(10):5951-5958
pubmed: 30275224
Eur J Cancer. 1996 Jul;32A(8):1314-9
pubmed: 8869092
Radiother Oncol. 1999 Aug;52(2):129-36
pubmed: 10577698
Radiother Oncol. 2013 Aug;108(2):337-41
pubmed: 24074814
Lancet. 1997 Jul 19;350(9072):161-5
pubmed: 9250182
Radiother Oncol. 2011 Mar;98(3):304-8
pubmed: 21345508
Int J Radiat Oncol Biol Phys. 1996 Oct 1;36(3):593-9
pubmed: 8948343
Radiat Oncol. 2013 Mar 05;8:49
pubmed: 23497555
J Natl Cancer Inst. 2011 Oct 5;103(19):1452-60
pubmed: 21903745
Radiother Oncol. 2013 Oct;109(1):8-12
pubmed: 24094626
Radiother Oncol. 1999 Aug;52(2):137-48
pubmed: 10577699
Front Oncol. 2013 Nov 18;3:286
pubmed: 24303369
J Thorac Dis. 2018 Aug;10(Suppl 21):S2465-S2473
pubmed: 30206492
Radiother Oncol. 2004 May;71(2):157-62
pubmed: 15110448
N Engl J Med. 2018 Dec 13;379(24):2342-2350
pubmed: 30280658
Lung Cancer. 2019 Aug;134:259-267
pubmed: 31319991
Syst Rev. 2015 Jan 01;4:1
pubmed: 25554246
Lung Cancer. 2013 Jul;81(1):144
pubmed: 23643277
Radiother Oncol. 2012 Nov;105(2):145-9
pubmed: 23068707
Int J Radiat Oncol Biol Phys. 2011 Nov 1;81(3):712-8
pubmed: 20932667
Cochrane Database Syst Rev. 2010 Jun 16;(6):CD002140
pubmed: 20556756
Am J Clin Oncol. 2000 Apr;23(2):207-12
pubmed: 10776986
J Clin Oncol. 2010 May 1;28(13):2181-90
pubmed: 20351327
J Natl Cancer Inst. 2016 May 19;108(9):
pubmed: 27206636
J Thorac Oncol. 2011 Jan;6(1):79-85
pubmed: 21150466
Radiat Oncol. 2007 Jul 23;2:27
pubmed: 17659094
BMC Cancer. 2013 Oct 31;13:513
pubmed: 24176164
J Clin Oncol. 2013 Dec 1;31(34):4343-8
pubmed: 24145340
Crit Rev Oncol Hematol. 2015 Nov;96(2):319-27
pubmed: 26095618
J Clin Oncol. 2012 Aug 1;30(22):2788-97
pubmed: 22753901
Br J Cancer. 1984 Sep;50(3):343-9
pubmed: 6087867
J Clin Oncol. 2005 Jun 1;23(16):3760-7
pubmed: 15837967
J Thorac Oncol. 2009 Jul;4(7):853-61
pubmed: 19487965
Lancet Oncol. 2015 Feb;16(2):187-99
pubmed: 25601342
Radiother Oncol. 2016 Mar;118(3):442-6
pubmed: 26900091
J Clin Oncol. 2017 Jan;35(1):56-62
pubmed: 28034064
J Clin Oncol. 2004 Nov 1;22(21):4329-40
pubmed: 15514374